Loading...
Market
How much will Eli Lilly's production output increase at the Limerick facility by the end of 2025?
2
Resolution / Starting Odds
Increase by more than 50% • 25%
Increase by 30-50% • 25%
Increase by 10-30% • 25%
Increase by less than 10% • 25%
Eli Lilly's official announcements, production reports, and news articles
Story
Eli Lilly to Invest $1.8 Billion in Irish Manufacturing, Creating 150 Jobs in Limerick
Sep 12, 2024, 09:49 AM
Eli Lilly is making a significant investment to expand its manufacturing capabilities in Ireland. The pharmaceutical company announced a $1.8 billion investment across two sites in Ireland, including a further €927 million investment at its facility in Raheen, Limerick. This expansion aims to boost the production of its blockbuster drugs for obesity, diabetes, and Alzheimer's disease, including biologic active ingredients. The investment is expected to create 150 additional jobs at the Limerick facility. Eli Lilly's move underscores its commitment to meeting the growing demand for its in-demand medicines, which help millions of people worldwide.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
More than $35 billion • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Weight loss drug • 25%
Diabetes drug • 25%
Alzheimer's drug • 25%
Other • 25%
Less than 10,000 units per month • 25%
10,000 to 50,000 units per month • 25%
50,001 to 100,000 units per month • 25%
More than 100,000 units per month • 25%
Less than $4.5 billion • 25%
$4.5 billion to $5 billion • 25%
$5 billion to $5.5 billion • 25%
More than $5.5 billion • 25%
Major success • 25%
Moderate success • 25%
Limited success • 25%
Failure • 25%